Objective-To make a retrospective and
Since the original description, in 1937, of Behcet's syndrome (BS) as a triple complex of recurrent oral and genital ulcers and uveitis, it has been shown that many organs and systems, including skin, joints, blood vessels, and the gastrointestinal (GI) system, can be affected. ' The frequency of GI involvement varies in different countries:" there are several studies, mostly from Japan, reporting a high frequency (50-60%) of GI involvement in BS,' 2 while a high frequency of GI involvement has not been found among Turkish patients (0-5%) reported as having other disease features.3 7 8 We undertook a formal survey of the frequency of inflammatory bowel disease in our patients with BS, using three methods. We reviewed the medical records of the first 1000 with ankylosing spondylitis) and 14 patients with ulcerative colitis whose records were selected from the archives of the pathology department were used as diseased controls. Table 2 gives details of the ages and genders of these control subjects. All specimens were read blind by a pathologist (NT) who graded the following items arbitrarily on a scale from 0 (none) to 3 (severe): destruction of surface epithelium; lymphoplasmocytic infiltration; polymorphonuclear infiltration; loss of goblet cells; loss of crypts.
All patients with Behcet's syndrome fulfilled biopsy specimens in asymptomatic patients from Turkey has also been described. '3 Therefore, in addition to our clinical survey for the presence of diarrhoea as an indicator of inflammatory bowel disease among our patients, we also undertook a controlled, blinded study of rectal biopsy specimens. It was notable from our questionnaire that there was no difference in the frequency of diarrhoea within the previous three months and at the time of the clinic visit (table 1). We do not have an explanation for the unexpected lower frequency of diarrhoea noted among the Behcet's patients seen during the period earlier than the preceding three months (X2 = 6-53, p < 0-02), though it may have been the result of underrecording of diarrhoea in the patients' charts. Alternatively, patients with diarrhoea may have sought medical attention elsewhere, with the result that we subsequently observed a lower frequency of diarrhoea in this group. These two potential biases arising from the retrospective part of the study must be taken into consideration in interpreting our results. Furthermore, while we did not find inflammatory changes of either moderate or severe degree in rectal biopsy specimens from patients with Behqet's syndrome, it is certainly possible that some of our patients may have had asymptomatic lesions at locations in the GI tract that we did not examine.
The results of this study in general parallel our earlier observation that, as judged by the symptom of diarrhoea, symptomatic inflammatory bowel disease is at best infrequent in Turkish patients with BS. This is in contrast to findings in Japan, where a high frequency (50-60%) of patients with BS were reported to have symptoms of inflammatory bowel disease such as diarrhoea, abdominal pain, and abdominal distension.' 2 There are also several case reports of similar GI involvement in Behcet's syndrome, including a case in a child.'4 However, in a well described series of 41 patients from Israel, no GI symptoms apart from oral aphthae were reported. 4 In the United Kingdom, three of 32 patients had gastrointestinal involvement, one of whom had proven Crohn's disease,5 and three of 10 patients reported from the USA had chronic colitis.6 Among 150 patients attending a surgical department at Ankara, Turkey, seven patients with involvement of the terminal ileum and the ileocaecal area required surgery,8 but we have found superficial ulcerations in the ileocaecal area in only one case among seven postmortem examinations in patients with BS who died from causes not related to GI (unpublished observations).
Geographical differences in the features of BS are not confined to the GI tract. A high frequency (about 80%) of both pathergy test positivity and HLA-B5 were encountered in patients from Japan and the Mediterranean countries including Turkey, in contrast to patients in the United Kingdom and the USA.'5 These variations in disease expression remain to be explained in this syndrome of unknown aetiology.
